Optibiotix Health Share Discussion Threads

[2350220] 14/3/2019 10:40

Interesting article, as you say Brad.
But even more so, when I looked down the page at the Police photographing a Driver doing 80mph, on cruise control, with both his feet on the dashboard!
It takes all sorts.
John

[judijudi] 14/3/2019 10:07

Also seems like poor stock control to me
Very poor business if you cannot fulfill orders for new customers
imho

[parob] 14/3/2019 08:57

Colin,Existing Seed customers continue to receive their monthly subscription so OPTI will continue to receive orders, it's just new customers that are on a waiting list. Gives you an idea of how popular the product is.

[brad44] 14/3/2019 08:56

hxxps://www.metro.news/heart-drug-a-lower-risk-to-patients-than-taking-statins/1473282/

interesting article.

[colinzeal] 14/3/2019 08:50

I see it's still on pre-order on the Seed website...let's hope they pull their finger out and get the stocks replenished asap.

[rayrac] 14/3/2019 08:26

It could mean that..or it could mean he’s looking to earn a living elsewhere, considering he lost a position at Opti?

Good luck to him, but he didnt come over as a dynamic person when shown on any link.

[scotty1] 14/3/2019 08:09

A tie up in the future perhaps.seeing as he is still NED at Opti.

[cyberbub] 13/3/2019 18:32

Does anyone know how many warrants and options are outstanding? A bit disappointing that the company didn't provide a summary in today's RNS, that would be best practice (see ARS yesterday for an example).

[imnotlong] 13/3/2019 16:02

Got all excited for a moment thinking it was going to be a big contract.

I hope these warrants get placed and don’t drip feed into the market.

[someuwin] 13/3/2019 16:00

...Christopher Atur Potts

[rafboy] 13/3/2019 15:52

Exercise of warrants RNS out.

[manneken] 13/3/2019 14:38

BoomBod & Slimfast are both using glucomannan etc in their products. Can we be certain they are not working in co-operation with Optibiotix? Or have I missed something?

[jamesrs1] 13/3/2019 13:40

One decent RNS and this will jump to £1. I see a lot of scepticism And impatient investors Wanting immediate figures and answers. This is holding well at 80p for a reason. Stronger now than ever before. £1.50 by Christmas.

[rayrac] 13/3/2019 13:24

Slimbiome is patented and will get granted. Some of the claims will get turned down which is typical & why patent claims are written very broadly & have multiple criteria. The longer it takes to grant is actually much more beneficial to Opti in terms of costs and future backdated royalties.

So it’s not granted! And only one username. :)

[riskybusiness1] 13/3/2019 12:56

Not sure if Rayrac has a moronic following or he's logging in to his other usernames to tick himself up AKA Dazah who is coincidently obsessed on the LSE board. Suspect the latter as I have faith genuine people are not so stupid to listen to an outright liar & serial misinformer.Slimbiome is patented and will get granted. Some of the claims will get turned down which is typical & why patent claims are written very broadly & have multiple criteria. The longer it takes to grant is actually much more beneficial to Opti in terms of costs and future backdated royalties.

[belgrano2] 13/3/2019 12:51

Excellent post risky..always someone wanting to steel your technology. Didn't know that DSM had tried something...got any more info on that. Hardly surprising when players see, like us just how marketable our range in becoming.

[rayrac] 13/3/2019 11:45

You go to the patent office to record a tm. But you are right.

No big issue...the big issue is can you patent the ingredients in slimbiome? Costly even if it can be done.

Takes your mind off the india trip eh and the lack of an rns?

[riskybusiness1] 13/3/2019 11:14

You can't patent a name it's called a trademark. Lol. The patents are application patents for specific ingredients used in combination in the weight management space. Dose will be irrelevant. SOH as the director of 3M Healthcare said it was the norm when looking at new science to instruct a team of patent attorneys to try and break patents behind technology that could be of value. DSM tried this with Optis prebiotic & failed. SOH is extremely knowledgable in building & protection of patents so simply ask him if you have any concerns as he knows exactly what he's doing.The process isn't apply and cross your fingers for luck, there is extensive advice & significant evidence required from patent attorneys when applying for a patent.

[anderson3] 13/3/2019 11:02

Hopefully see an RNS soon, with regards to Fred tucking a few shares away

[rayrac] 13/3/2019 10:54

Well, we know the slimbiome name is patented? But the ingredients will be another matter perhaps? Formulation percentages would have to be declared maybe? But they surely can be different from one company to another’s, product? Even if just slightly.

[riskybusiness1] 13/3/2019 10:48

As soon as the patent is filed & pending your protected & anyone infringing risks a later lawsuit. This is why SOH wanted to build the IP portfolio and file the patents to sweetbiotix before having serious discussions with major partners that would immediately try & get round the patents. During the pending stage they can copy but as soon as the patent is granted a claim will be made and royalties will backdated. Opti can serve them a letter letting them know about the patent pending now or let them build sales and become established & then serve them later for more cash.You can get round any patent ever existed if you put enough effort in. SOH has built multiple layers of protection making this a time consuming & pointless to corporates.

[someuwin] 13/3/2019 10:23

But AFAIK the patents are still at the pending stage. I'm sure they would have RNS'd a patent being granted.

From the OPTI Admission Document...

Intellectual Property

The Enlarged Group is focused on protecting its intellectual property (“IP”) and seeking to avoid infringing on third parties’ IP. To protect its products, the Enlarged Group is securing patents to protect its key products. However, there remains the risk that the Enlarged Group may face opposition from third parties to patents that it seeks to have granted and that the outstanding patent applications are not granted. The Enlarged Group engages legal advisers to mitigate the risk of patent infringement and to assist with the protection of the Enlarged Group’s IP.

The Enlarged Group’s success will depend in part on its ability to maintain adequate protection of its intellectual property portfolio. The intellectual property on which the Enlarged Group’s business is based is a combination of patent applications and confidential know-how. No assurance can be given that any pending patent applications or any future patent applications will result in granted patents, that any patents will be granted on a timely basis, that the scope of any patent protection will exclude competitors or provide competitive advantages to the Enlarged Group, that any of the Enlarged Group’s patents will be held valid if challenged, or that third parties will not claim rights in, or ownership of, the patents and other proprietary rights held by the Enlarged Group.

There is a risk that certain objections may be raised by patent offices in relation to the on-going patent applications which have been filed by the Enlarged Group. These may result in revised applications or prevent those patent applications from being granted. If the patent applications are not granted, the consequence is that the techniques and processes described in the patent applications would not be protected and would be in the public domain. The Enlarged Group would then continue to rely on the confidential know- how it has developed.